KFDA to exempt drug reviews on newly registered items.

Published: 2004-05-28 06:59:00

Updated: 2004-05-28 06:59:00

KFDA disclosed in public the draft of the Drug Review regulation and Narcotic Drug Act on May 24 purported to revise relevant provisions pertaining to the drug review and narcotic drug controls in its terminology and other operational weakness surfaced during the implementation of the provision.

The draft prescribed the drug review program not to be applicable for the drug elapsed no more th...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.